Kim Van der Eecken

Journal Article
A1
open access

Clinical and genomic differences between advanced molecular imaging-detected and conventional imaging-detected metachronous oligometastatic castration-sensitive prostate cancer

Philip Sutera, Yang Song, Kim Van der Eecken (UGent) , Amol C Shetty, Keara English, Theresa Hodges, Jinhee Chang, Valerie Fonteyne (UGent) , Zaker Rana, Lei Ren, et al.

(2023) EUROPEAN UROLOGY.

Add to list

WNT pathway mutations in metachronous oligometastatic castration-sensitive prostate cancer

Philip Sutera, Matthew P. Deek, Kim Van der Eecken (UGent) , Amol C. Shetty, Jin Hee Chang, Theresa Hodges, Yang Song, Sofie Verbeke (UGent) , Jo Van Dorpe (UGent) , Valerie Fonteyne (UGent) , et al.

(2023) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 115(5). p.1095-1101

Add to list

Journal Article
A1
open access

Whole slide imaging-based prediction of TP53 mutations identifies an aggressive disease phenotype in prostate cancer

Marija Pizurica (UGent) , Maarten Larmuseau (UGent) , Kim Van der Eecken (UGent) , Louise de Schaetzen van Brienen (UGent) , Francisco Carrillo-Perez, Simon Isphording (UGent) , Nicolaas Lumen (UGent) , Jo Van Dorpe (UGent) , Piet Ost (UGent) , Sofie Verbeke (UGent) , et al.

(2023) CANCER RESEARCH. 83(17). p.2970-2984

Add to list

Towards the discovery of prognostic and predictive biomarkers in CHEERS, a radioimmunotherapy phase II trial

Jan Vanwelkenhuyzen (UGent) , Mathieu Spaas (UGent) , Kim Van der Eecken (UGent) , Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Lieve Brochez (UGent) , Johan Lindberg, Katleen De Preter (UGent) , Bram De Laere (UGent) and Piet Ost (UGent)

(2022) OncoPoint Symposium 2022, Abstracts.

Add to list

PhD Thesis

Unraveling the genomic underpinnings of advanced prostate cancer

Kim Van der Eecken (UGent)

(2022)

Add to list

Genomic features of lung-recurrent hormone-sensitive prostate cancer

Nicolette M. Fonseca, Kim Van der Eecken (UGent) , Cameron Herberts, Sofie Verbeke (UGent) , Sarah W.S. Ng, Nicolaas Lumen (UGent) , Elie Ritch, Andrew J. Murtha, Cecily Q. Bernales, Elena Schönlau, et al.

(2022) JCO PRECISION ONCOLOGY. 6.

Add to list

Shallow whole-genome sequencing : a useful, easy to apply molecular technique for CNA detection on FFPE tumor tissue : a glioma-driven study

Kim Van der Eecken (UGent) , Malaïka Van der Linden (UGent) , Lennart Raman, David Creytens (UGent) , Franceska Dedeurwaerdere, Koen De Winne, Liesbeth Ferdinande (UGent) , Martin Lammens, Björn Menten (UGent) , Isabelle Rottiers (UGent) , et al.

(2022) VIRCHOWS ARCHIV. 480. p.677-686

Add to list

Tissue- and blood-derived genomic biomarkers for metastatic hormone-sensitive prostate cancer : a systematic review

Kim Van der Eecken (UGent) , Jan Vanwelkenhuyzen (UGent) , Matthew P. Deek, Phuoc T. Tran, Evan Warner, Alexander W. Wyatt, Edmond M. Kwan, Sofie Verbeke (UGent) , Jo Van Dorpe (UGent) , Valerie Fonteyne (UGent) , et al.

(2021) EUROPEAN UROLOGY ONCOLOGY. 4(6). p.914-923

Add to list

Conference Paper
C3
open access

Clinical and genomic indolence in lung-recurrent metastatic hormone-sensitive prostate cancer

Nicolette Fonseca, Kim Van der Eecken (UGent) , Cameron Herberts, Sofie Verbeke (UGent) , Sarah Ng, Nicolaas Lumen (UGent) , Elie Ritch, Andrew Murtha, Cecily Bernales, Elena Schönlau, et al.

(2021) Global Congress on Prostate and Bladder Cancer 2021, Abstracts.

Add to list

Conference Paper
C3
open access

Multifocality in prostate cancer : implications for PAM50 subtyping using an index lesion-only approach

Kim Van der Eecken (UGent) , Maarten Larmuseau (UGent) , Jan Vanwelkenhuyzen (UGent) , Nicolaas Lumen (UGent) , Kathleen Marchal (UGent) , Jo Van Dorpe (UGent) , Piet Ost (UGent) , Bram De Laere (UGent) and Sofie Verbeke (UGent)

(2021) Global Congress on Prostate and Bladder Cancer 2021, Abstracts.

Academic Bibliography

Kim Van der Eecken

Clinical and genomic differences between advanced molecular imaging-detected and conventional imaging-detected metachronous oligometastatic castration-sensitive prostate cancer

WNT pathway mutations in metachronous oligometastatic castration-sensitive prostate cancer

Whole slide imaging-based prediction of TP53 mutations identifies an aggressive disease phenotype in prostate cancer

Towards the discovery of prognostic and predictive biomarkers in CHEERS, a radioimmunotherapy phase II trial

Unraveling the genomic underpinnings of advanced prostate cancer

Genomic features of lung-recurrent hormone-sensitive prostate cancer

Shallow whole-genome sequencing : a useful, easy to apply molecular technique for CNA detection on FFPE tumor tissue : a glioma-driven study

Tissue- and blood-derived genomic biomarkers for metastatic hormone-sensitive prostate cancer : a systematic review

Clinical and genomic indolence in lung-recurrent metastatic hormone-sensitive prostate cancer

Multifocality in prostate cancer : implications for PAM50 subtyping using an index lesion-only approach

Contents

Support

Contact